Psychedelic Sector Data Bank
The rapid growth of the psychedelics space has not been matched by the provision of accessible, curated data on matters such as the filing of patents or the progression of decriminalization and legalization initiatives.
Our Data Bank is a window into some of this formerly disparate data. ∎
Our data have been cited in:
Psychedelic Patent Trackers
Curated by Calyx Law, our patent trackers catalogue published patents across a number of molecules, including psilocybin, DMT and MDMA.
Psilocybin Patent Tracker
A catalogue of U.S. psilocybin-related patent publications.
Ibogaine Patent Tracker
A catalogue of U.S. ibogaine-related patents, where publicly announced.
Ketamine Patent Tracker
A catalogue of U.S. ketamine-related patents, where publicly announced.
Other Trackers and Resources
Decriminalization and legalization; drug development pipelines; and an overview of the psychedelics value chain…
Looking for something else?
We might have what you’re looking for. Send us an email to discuss. ∎